Risk of Dilution in Equity Value from Stock Options
First written in FY2018. 18 of 22 entries say "Materialised", first in FY2019-Q1. Latest entry: FY2025.
eXmotion moved to the "Worse" side of this theme in 2019, 1 year before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「Exercise of rights 9,800 Unexercised balance －」
All 9,800 shares under the second series of stock acquisition rights outstanding at the end of the previous fiscal year were exercised, leaving no unexercised balance. The potential for additional dilution from potential shares has declined. - FY2023MitigatedAnnual report
「As of 31 January 2024, the number of potential shares from stock options was 9,800, equivalent to 0.3% of the total number of issued shares.」
All of the third series of stock acquisition rights were exercised. The unexercised balance of the second series was 9,800 shares, and the potential share ratio declined from 2.0% in the previous fiscal year to 0.3%. - FY2023-Q3MaterialisedAnnual report
「1 June 2023–31 August 2023 (Note) 9,000 2,987,800 690 451,351 690 442,351 (Note) Increase due to the exercise of stock acquisition rights.」
The number of shares increased by 9,000 through the exercise of stock acquisition rights in the third quarter, while capital and the capital reserve each increased by ¥690 thousand. The potential dilution from stock options continued to be reflected in actual share issuances. - FY2023-Q2MaterialisedAnnual report
「1 March 2023–31 May 2023 (Note) 1 7,500 2,978,800 575 450,660 575 441,660 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 June 2023 and 30 June 2023, the total number of issued shares increased by 6,000, and capital and the capital reserve each increased by ¥460 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 7,500 through the exercise of stock acquisition rights in the second quarter, followed by a further increase of 6,000 after the quarter-end. The potential dilution from stock options continued to be reflected in actual share issuances. - FY2023-Q1MaterialisedAnnual report
「1 December 2022–28 February 2023 (Note) 1 7,500 2,971,300 575 450,085 575 441,085 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 March 2023 and 31 March 2023, the total number of issued shares increased by 1,500, and capital and the capital reserve each increased by ¥115 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 7,500 through the exercise of stock acquisition rights in the first quarter, followed by a further increase of 1,500 after the quarter-end. The potential dilution from stock options continues to be reflected in actual share issuances. - FY2022MitigatedAnnual report
「As of 31 January 2023, the number of potential shares from stock options was 60,200, equivalent to 2.0% of the total number of issued shares. If these stock options are exercised, new shares will be issued, potentially diluting the value of the shares.」
While the potential share ratio declined from 2.7% in the previous fiscal year to 2.0%, the number of shares increased by 16,500 through the exercise of stock acquisition rights during the fiscal year, so the potential dilution remains. - FY2022-Q3MaterialisedAnnual report
「1 June 2022–31 August 2022 (Note) 1,500 2,954,800 115 448,824 115 439,824 (Note) Increase due to the exercise of stock acquisition rights.」
The number of shares increased by 1,500 through the exercise of stock acquisition rights in the third quarter, while capital and the capital reserve each increased by ¥115 thousand. The potential dilution from stock options continues to be reflected in actual share issuances. - FY2022-Q2MaterialisedAnnual report
「1 March 2022–31 May 2022 (Note) 1 4,900 2,953,300 373 448,708 373 439,708 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 June 2022 and 30 June 2022, the total number of issued shares increased by 1,500, and capital and the capital reserve each increased by ¥115 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 4,900 through the exercise of stock acquisition rights in the second quarter, followed by a further increase of 1,500 after the quarter-end. The potential dilution from stock options continues to be reflected in actual share issuances. - FY2022-Q1MaterialisedAnnual report
「1 December 2021–28 February 2022 (Note) 1 1,100 2,948,400 84 448,335 84 439,335 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 March 2022 and 31 March 2022, the total number of issued shares increased by 3,300, and capital and the capital reserve each increased by ¥253 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 1,100 through the exercise of stock acquisition rights in the first quarter, followed by a further increase of 3,300 after the quarter-end. The potential dilution continues to be reflected in actual share issuances. - FY2021MaterialisedAnnual report
「The total number of issued shares increased by 39,600 through the exercise of stock acquisition rights between 1 December 2020 and 30 November 2021. As of 31 January 2022, the number of potential shares from stock options was 77,100, equivalent to 2.7% of the total number of issued shares.」
The issuance of shares through the exercise of stock acquisition rights continued throughout the fiscal year, with the potential dilution reflected in an increase in the number of issued shares. The number of potential shares before the filing date was 77,100, or 2.7%. - FY2021-Q3MaterialisedAnnual report
「1 June 2021–31 August 2021 (Note) 1 7,000 2,929,100 537 446,854 537 437,854 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 September 2021 and 30 September 2021, the total number of issued shares increased by 6,200, and capital and the capital reserve each increased by ¥475 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 7,000 through the exercise of stock acquisition rights in the third quarter, followed by a further increase of 6,200 after the quarter-end. The potential dilution from stock options continues to be reflected in actual share issuances. - FY2021-Q2MaterialisedAnnual report
「1 June 2021– 31 May 2021 (Note) 7,000 2,922,100 535 446,317 535 437,317 (Note) Increase due to the exercise of stock acquisition rights.」
From March to May 2021, the number of shares increased by 7,000 through the exercise of stock acquisition rights, while capital and the capital reserve each increased by ¥535 thousand. The potential dilution from stock options continues to be reflected in actual share issuances. - FY2021-Q1MaterialisedAnnual report
「1 December 2020–28 February 2021 (Note) 1 7,400 2,915,100 567 445,781 567 436,781 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 March 2021 and 31 March 2021, the total number of issued shares increased by 3,000, and capital stock and capital surplus each increased by ¥230 thousand through the exercise of stock acquisition rights.」
The number of shares increased by 7,400 during the quarter through the exercise of stock acquisition rights, and an additional increase of 3,000 shares occurred during the period before the filing date. - FY2020MaterialisedAnnual report
「The total number of issued shares increased by 110,600 through the exercise of stock acquisition rights between 1 December 2019 and 30 November 2020.」
Share issuance through the exercise of stock acquisition rights continued throughout the fiscal year, with the potential dilution materializing as an actual increase in the number of issued shares. - FY2020-Q3MaterialisedAnnual report
「1 June 2020–31 August 2020 (Note) 27,100 2,849,500 2,075 440,774 2,075 431,774 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, the number of shares increased by 27,100 through the exercise of stock acquisition rights, and capital stock and capital surplus each increased by ¥2,075 thousand. The potential dilution continues to materialize as actual share issuance. - FY2020-Q2MaterialisedAnnual report
「1 March 2020–31 May 2020 (Note) 1 25,300 2,822,400 1,940 438,699 1,940 429,699 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 June 2020 and 30 June 2020, the total number of issued shares increased by 3,300, and capital stock and capital surplus each increased by ¥253 thousand through the exercise of stock acquisition rights.」
During the second quarter, 25,300 shares were issued through the exercise of stock acquisition rights, and a further 3,300 shares were issued after the quarter-end. The potential dilution from stock options continues to materialize as actual increases in shares. - FY2020-Q1MaterialisedAnnual report
「(Note) Between 1 March 2020 and 31 March 2020, the total number of issued shares increased by 12,300, and capital stock and capital surplus each increased by ¥922 thousand through the exercise of stock acquisition rights.」
After the quarter-end, 12,300 shares were issued through the exercise of stock acquisition rights, with the potential dilution from stock options additionally materializing as an actual increase in shares. - FY2019MaterialisedAnnual report
「The total number of issued shares increased by 147,700 through the exercise of stock acquisition rights between 1 June 2019 and 30 November 2019. As of 31 January 2020, the number of potentially dilutive shares from stock options was 228,400, equivalent to 8.2% of the total number of issued shares.」
Share issuance through the exercise of stock acquisition rights has continued, with the dilution risk materializing as an actual increase in the number of shares. - FY2019-Q3MaterialisedAnnual report
「In addition, during the nine-month period ended this quarter, capital stock and capital surplus each increased by ¥18,390 thousand through the exercise of stock acquisition rights. 3. Between 1 September 2019 and 30 September 2019, the total number of issued shares increased by 133,000, and capital stock and capital surplus each increased by ¥9,975 thousand through the exercise of stock acquisition rights.」
During the nine-month period ended this quarter, shares were issued and capital stock and capital surplus increased through the exercise of stock acquisition rights. In addition, the issuance of 133,000 shares through the filing date is reported. The potential dilution from potentially dilutive shares continues to materialize as actual share issuance. - FY2019-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between 1 March 2019 and 31 May 2019, the total number of issued shares increased by 4,300 through the exercise of stock acquisition rights, with the potential dilution from potentially dilutive shares additionally materializing as actual share issuance. - FY2019-Q1MaterialisedAnnual report
「1 December 2018–28 February 2019 100 1,320,400 15 425,037 15 416,037 Increase due to the exercise of stock acquisition rights.」
During the quarter, 100 shares were issued through the exercise of stock acquisition rights, with part of the potential dilution from potentially dilutive shares materializing as an actual share issuance. - FY2018First statedAnnual report
「As of 31 January 2019, the number of potentially dilutive shares from stock options was 197,700, equivalent to 15.0% of the total number of issued shares. If these stock options are exercised, new shares will be issued and the value of the shares may be diluted.」
Quantifies the potential dilution risk, with 197,700 potentially dilutive shares representing 15.0% of the total number of issued shares.